UK markets close in 6 hours 52 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
286.26+4.30 (+1.53%)
At close: 4:00PM EDT
289.35 +3.09 (1.08%)
Pre-market: 04:38AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close281.96
Bid0.00 x 900
Ask0.00 x 1100
Day's range276.68 - 297.72
52-week range54.10 - 297.72
Avg. volume3,118,343
Market cap69.138B
Beta (5Y monthly)N/A
PE ratio (TTM)52.27
EPS (TTM)5.48
Earnings date09 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est200.87
  • Editor's pick
    Yahoo Finance Video

    Doctor on COVID-19 vaccination: ‘Too little too late, better late than never, if anything it all counts’

    Dr. Calvin Sun,The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

  • Motley Fool

    After Covid, BioNTech Has Its Sights Set on Malaria

    BioNTech entered 2020 as a well-respected — if a bit under-the-radar — biotech company. A little more than a year later, the firm is...

  • Why BioNTech Rose as Much as 5% Today
    Motley Fool

    Why BioNTech Rose as Much as 5% Today

    Coronavirus stock BioNTech (NASDAQ: BNTX) was a winner on Monday. BioNTech announced Monday that it has launched a project aimed at developing a malaria vaccine based on the messenger RNA (mRNA) technology that underpins BNT162b2. The biotech said this program, "will assess multiple vaccine candidates featuring known Malaria targets ... as well as new antigens discovered in the pre-clinical research phase."